These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 2994624)

  • 41. [The efficacy of foot and mouth disease vaccines after long- term storage].
    Wittmann G
    Berl Munch Tierarztl Wochenschr; 1980 Jan; 93(2):33-4. PubMed ID: 6248022
    [No Abstract]   [Full Text] [Related]  

  • 42. [Determination of the antibody titer in vaccination against foot-and-mouth disease of animals].
    Priskoka VA; Sobko AI; Dudnikov AI
    Veterinariia; 1975 May; (5):51-3. PubMed ID: 1209953
    [No Abstract]   [Full Text] [Related]  

  • 43. Foot-and-mouth disease vaccination: a multifactorial study of the influence of antigen dose and potentially competitive immunogens on the response of cattle of different ages.
    Black L; Nicholls MJ; Rweyemamu MM; Ferrari R; Zunino MA
    Res Vet Sci; 1986 May; 40(3):303-7. PubMed ID: 3016849
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protection against viral infections with the aid of synthetic peptides. Foot-and-mouth disease as an example.
    Vol'pina OM; Surovoi AYu ; Ivanov VT
    Biomed Sci; 1990 Jan; 1(1):23-32. PubMed ID: 1718462
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A review of the current status of oil adjuvants in foot--and--mouth disease vaccines.
    McKercher PD; Graves JH
    Dev Biol Stand; 1976; 35():107-12. PubMed ID: 198275
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Post-vaccinal immunity against heterologous subtypes of the foot-and-mouth disease virus].
    Sobko AI; Sokolov LN; Mishchenko VA; Maslova NS; Dudnikov AI
    Veterinariia; 1977 Sep; (9):42-4. PubMed ID: 202059
    [No Abstract]   [Full Text] [Related]  

  • 47. Use of new adjuvants in an emergency vaccine against foot-and-mouth disease virus: evaluation of conferred immunity.
    Quattrocchi V; Bianco V; Fondevila N; Pappalardo S; Sadir A; Zamorano P
    Dev Biol (Basel); 2004; 119():481-97. PubMed ID: 15742663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.
    Golde WT; Pacheco JM; Duque H; Doel T; Penfold B; Ferman GS; Gregg DR; Rodriguez LL
    Vaccine; 2005 Dec; 23(50):5775-82. PubMed ID: 16153756
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Residual foot-and-mouth disease virus antibodies in French cattle and sheep six years after the vaccination ban.
    Remond M; Kaiser C; Lebreton FO; Moutou F; Crucière C
    Vet Res; 2001; 32(1):81-6. PubMed ID: 11254180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Experiments on an early protection against foot-and-mouth disease virus.
    Liebermann HT; Thalmann G; Bartels T; Nöckler A
    Acta Virol; 1993; 37(2-3):181-3. PubMed ID: 8105663
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vaccination against foot-and-mouth disease.
    Morgan DO; Moore DM; McKercher PD
    Prog Clin Biol Res; 1980; 47():169-78. PubMed ID: 6259663
    [No Abstract]   [Full Text] [Related]  

  • 52. [Correlation between 146S antigen dosage and antibody titers after foot-and-mouth disease vaccination in cattle and swine].
    Liebermann HT; Thalmann G; Nöckler A; Felfe P
    Arch Exp Veterinarmed; 1988 Jul; 42(4):528-36. PubMed ID: 2847677
    [No Abstract]   [Full Text] [Related]  

  • 53. [Attempts to demonstrate secretory antibodies in swine immune to foot-and-mouth disease (FMD) and intranasal immunization of pigs against the disease].
    Wittmann G
    Zentralbl Veterinarmed B; 1972 Nov; 19(9):779-81. PubMed ID: 4650802
    [No Abstract]   [Full Text] [Related]  

  • 54. Immune response of neonatal swine to inactivated foot-and-mouth disease virus vaccine with oil adjuvant. I. Influence of colostral antibody.
    Morgan DO; McKercher PD
    Proc Annu Meet U S Anim Health Assoc; 1977; (81):244-55. PubMed ID: 220635
    [No Abstract]   [Full Text] [Related]  

  • 55. [Humoral immune response in cattle vaccinated against aphthovirus. Study of the kinetics of protective and neutralizing antibodies].
    Rojas GB; Rottenberg ME; Brunengo AM
    Rev Argent Microbiol; 1984; 16(4):195-208. PubMed ID: 6101040
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunoglobulin profiles in nasal and buccal secretions from normal crossbred calves after vaccination with inactivated virus and/or experimental exposure to foot-and-mouth disease virus type Asia I.
    Kapil S; Ahuja KL; Prasad S
    Adv Exp Med Biol; 1987; 216B():1831-8. PubMed ID: 2827446
    [No Abstract]   [Full Text] [Related]  

  • 57. [Diagnosis and control of bovine enzootic leukosis. 4. Comparison of antibody formation following inoculation of the Riems concentrated foot-and-mouth disease vaccine in clinicially healthy and in pre-leukotic cattle].
    Seils H; Wittmann W; Weyhe D
    Arch Exp Veterinarmed; 1971 Jun; 25(3):581-6. PubMed ID: 4330772
    [No Abstract]   [Full Text] [Related]  

  • 58. Foot-and-mouth disease vaccine production and research in The Netherlands.
    Barteling SJ
    Vet Q; 1987 Nov; 9 Suppl 1():5S-15S. PubMed ID: 2829411
    [No Abstract]   [Full Text] [Related]  

  • 59. Development of an effective vaccine against foot-and-mouth disease with partially purified and concentrated virus antigen.
    Sen AK; Saha SN
    Acta Virol; 1994 Feb; 38(1):17-9. PubMed ID: 8067308
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Dynamics of formation of immunity in sheep vaccinated with different doses of foot-and-mouth disease vaccine from lapinized virus A22].
    Rakhmanin PP; Alekhin RM; Antoniuk VP; Darda PN; Kruglikov BA
    Veterinariia; 1977 Jan; (1):49-51. PubMed ID: 855170
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.